KRAS and carcinoma: Regarding CMS categorization, although no study has been reported in interval CRC, a higher proportion of screen-detected cancers could be hypothesized to be CSM2 and CMS3 because the tumors have an adenoma-carcinoma 10-year interval and KRAS mutations.